Loading...

Stevia Corp. Investor Conference Call - January 29, 2015 - (OTCQB: STEV)

3,355 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Feb 1, 2015

INDIANAPOLIS, IN – Stevia Corp. (OTCQB: STEV), an international farm management company and healthcare company focused on the commercial development of products that support a healthy lifestyle, including stevia and hemp and their compounds, is pleased to announce that the company has hosted a conference call on January 29, 2015 at 4:30 PM EST to discuss recent corporate news and its business goals for 2015. We would like to take this opportunity to welcome all our shareholders. To all other interested parties, we hope you find this call interesting and informative.

http://www.steviacorp.com
http://www.realhemp.com
http://www.realhempstore.com
http://www.highcbd.com

Newsletter: http://steviacorp.us9.list-manage.com...

---

PRESS RELEASES:

Stevia Corp. Confirms Protocol to Produce Synthetic CBD: http://www.marketwired.com/press-rele...

Stevia Corp. Appoints Dr. Jerry Smartt to Board of Directors and Welcomes Veteran Research Scientist to Advisory Board: http://www.marketwired.com/press-rele...

Stevia Corp. Files Key Provisional Patent Application With the United States Patent and Trademark Office for Cannabidiol (CBD) and Acetaminophen Formulation to Treat Pain: http://www.marketwired.com/press-rele...

Stevia Corp. Files Second Key Provisional Patent Application with the United States Patent and Trademark Office for a Cannabidiol (CBD) and Ibuprofen Formulation to Treat Pain: http://www.prnewswire.com/news-releas...

Stevia Corp. Provides Spring Harvest Guidance: http://www.marketwired.com/press-rele...

Stevia Corp. Files Two Additional Provisional Patent Applications With the United States Patent and Trademark Office for a Cannabidiol (CBD) and Aspirin Formulation and a Cannabidiol and Naproxen Formulation to Treat Pain and Cardiovascular Disease: http://www.marketwired.com/press-rele...

Loading...


to add this to Watch Later

Add to

Loading playlists...